SpringWorks Therapeutics has announced that it anticipates receiving an opinion from the Committee for Medicinal Products for Human Use (CHMP) in the second quarter of 2025 regarding the use of Nirogacestat for treating adults with desmoid tumors in the European Union.
Latest articles
Business
India’s Strong Growth, Stability Ideal for Long-Term Investment: RBI Governor
The Reserve Bank of India (RBI) Governor, Sanjay Malhotra, advocated for India as a...
Finance News
Uber Considers Exiting Colorado Over Proposed Rider Safety Bill
Uber and Waymo have initiated autonomous transportation services in Austin, Texas. Meanwhile, Uber has...
News
4chan Returns Online, Claims Financial Strain
4chan has partially resumed operations after a hack incapacitated the well-known image-sharing platform for...
More like this
Business
India’s Strong Growth, Stability Ideal for Long-Term Investment: RBI Governor
The Reserve Bank of India (RBI) Governor, Sanjay Malhotra, advocated for India as a...
Finance News
Uber Considers Exiting Colorado Over Proposed Rider Safety Bill
Uber and Waymo have initiated autonomous transportation services in Austin, Texas. Meanwhile, Uber has...
News
4chan Returns Online, Claims Financial Strain
4chan has partially resumed operations after a hack incapacitated the well-known image-sharing platform for...